'Patent expiry' diaporamas de présentation

542 views • 38 slides

Week 13

459 views • 31 slides

458 views • 28 slides

GTX: An opportunity not to be missed?

268 views • 16 slides

Aarkstore - Metastatic Breast Cancer-Global API Manufacturer

Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Breast Cancer. Browse full report @ http://bit.ly/1wgFgSu

282 views • 11 slides

Aarkstore - Metastatic Colorectal Cancer-Global API Manufact

Metastatic Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Colorectal Cancer. Browse full report @ http://bit.ly/1aJpHP4

285 views • 11 slides

Aarkstore - Metastatic Prostate Cancer

Metastatic Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Prostate Cancer. Browse full report @ http://bit.ly/1wdcwzs

299 views • 11 slides

Aarkstore - Metastatic Melanoma-Global API Manufacturers

Metastatic Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Melanoma. Browse full report @ http://bit.ly/18pHhFU

216 views • 11 slides

Aarkstore - Meningitis

Meningitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Meningitis. Browse full report @ http://bit.ly/1Af0SQT

237 views • 11 slides

Aarkstore - Migraine

Migraine-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Migraine. Browse full report @ http://bit.ly/18hwGND

235 views • 11 slides

Aarkstore - Metastatic Nonseminomatous Testicular Cancer

Metastatic Nonseminomatous Testicular Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Nonseminomatous Testicular Cancer. Browse full report @ http://bit.ly/1Mx6RXf

249 views • 11 slides

Aarkstore - Metastatic Ovarian Cancer

Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Ovarian Cancer. Browse full report @ http://bit.ly/1Ls5dLa

250 views • 11 slides

Aarkstore - Moderate Pain

Moderate Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Moderate Pain. Browse full report @ http://bit.ly/19yaEYf

232 views • 11 slides

Aarkstore - Metastatic Pancreatic Cancer

Metastatic Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Pancreatic Cancer. Browse full report @ http://bit.ly/1N6x2Gb

318 views • 11 slides

Aarkstore - Multiple Myeloma (Kahlers Disease)

Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Multiple Myeloma (Kahler's Disease). Browse full report @ http://bit.ly/1BKX9dL

274 views • 11 slides

Aarkstore - Metastatic Renal Cell Carcinoma

The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Metastatic Renal Cell Carcinoma Browse full report @ http://bit.ly/1CZ3W8C

264 views • 11 slides

Yersinia Pestis Infections-Global API Manufacturers, Markete

238 views • 8 slides

Anti-hypertension Drug Pipeline Analysis and Market Forecast

The Anti-hypertension Market Is Expected to Witness Steep Decline Due to the Patent Expiry of Blockbusters. GlobalData estimated the global anti-hypertension market in 2009 at $36.9 billion, indicating a compound annual growth rate (CAGR) of 5.3% between 2001 and 2009.

713 views • 4 slides